Philippines - English - FDA (Food And Drug Administration)

alternative platform exchange inc.; importer: n/a; distributor: n/a - thiamazole - tablet - 5mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: n/a; distributor: alternative platform exchange, inc. - risperidone - tablet - 2 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: bliss pharma distribution and consultancy corp; distributor: alternative platform exchange, inc. - febuxostat - film-coated tablet - 40 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: medinova pharmaceutical inc.; distributor: alternative platform exchange, inc. - telmisartan , hydrochlorothiazide - tablet - 40 mg/12.5 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: pharmakon biotec inc; distributor: alternative platform exchange, inc - etoricoxib - film-coated tablet - 90 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: bliss pharma distribution and consultancy corp.; distributor: alternative platform exchange, inc - febuxostat - film-coated tablet - 40 mg

United States - English - NLM (National Library of Medicine)

rebel distributors corp - nizatidine (unii: p41pml4ghr) (nizatidine - unii:p41pml4ghr) - nizatidine 150 mg - nizatidine is indicated for up to 8 weeks for the treatment of active duodenal ulcer. in most patients, the ulcer will heal within 4 weeks. nizatidine is indicated for maintenance therapy for duodenal ulcer patients, at a reduced dosage of 150 mg h.s. after healing of an active duodenal ulcer. the consequences of continuous therapy with nizatidine for longer than 1 year are not known. nizatidine is indicated for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis, including erosive and ulcerative esophagitis, and associated heartburn due to gerd. nizatidine is indicated for up to 8 weeks for the treatment of active benign gastric ulcer. before initiating therapy, care should be taken to exclude the possibility of malignant gastric ulceration.

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, inc. - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8) - fosinopril sodium 20 mg - fosinopril sodium tablets are indicated for the treatment of hypertension. they may be used alone or in combination with thiazide diuretics. fosinopril sodium tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see dosage and administration). in using fosinopril sodium tablets, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril sodium does not have a similar risk (see warnings ). in considering use of fosinopril sodium tablets, it should be noted that in controlled trials ace inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. in addition, ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non

United States - English - NLM (National Library of Medicine)

rebel distributors corp. - benazepril hydrochloride (unii: n1sn99t69t) (benazepril - unii:udm7q7qwp8) - benazepril hydrochloride 5 mg - benazepril hydrochloride tablets are indicated for the treatment of hypertension. they may be used alone or in combination with thiazide diuretics. in using benazepril hydrochloride tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that benazepril hydrochloride does not have a similar risk (see warnings ). black patients receiving ace inhibitors have been reported to have a higher incidence of angioedema compared to nonblacks. it should also be noted that in controlled clinical trials ace inhibitors have an effect on blood pressure that is less in black patients than in nonblacks. benazepril hydrochloride tablets are contraindicated in patients who are hypersensitive to this product or to any other ace inhibitor.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - quinapril hydrochloride (unii: 33067b3n2m) (quinapril - unii:rj84y44811) - quinapril 5 mg - quinapril tablets are indicated for the treatment of hypertension. it may be used alone or in combination with thiazide diuretics. in using quinapril tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease. available data are insufficient to show that quinapril tablets does not have a similar risk (see warnings ). black patients receiving ace inhibitor monotherapy have been reported to have a higher incidence of angioedema compared to non-blacks. it should also be noted that in controlled clinical trials ace inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. quinapril is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an ace inhibitor.